Barbara Drogoszewska

Dr. Barbara Drogoszewska


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2020 in Materials
Verified
Journal Article
Open access
PDF file
MLMagdalena Lisiak-Myszke
Magdalena Lisiak-Myszke
DMDawid Marciniak
Dawid Marciniak
MBMarek Bieliński
Marek Bieliński
HSHanna Sobczak-Jaskow
Hanna Sobczak-Jaskow
ŁGŁukasz Garbacewicz
Łukasz Garbacewicz
BDBarbara Drogoszewska
Barbara Drogoszewska
In recent years in the field of biomechanics, the intensive development of various experimental methods has been observed. The implementation of virtual studies that for a long time have been successfully used in technical sciences also represents a new trend in dental engineering. Among these methods, finite element analysis (FEA) deserves special attention. FEA is a method used to analyze stresses and strains in complex mechanical systems. It enables the mathematical conversion and analysis of mechanical properties of a geometric object. Since the mechanical properties of the human skeleton cannot be examined in vivo, a discipline in which FEA has found particular application is oral and maxillofacial surgery. In this review we summarize the application of FEA in particular oral and maxillofacial fields such as traumatology, orthognathic surgery, reconstructive surgery and implantology presented in the current literature. Based on the available literature, we discuss the methodology and results of research where FEA has been used to understand the pathomechanism of fractures, identify optimal osteosynthesis methods, plan reconstructive operations and design intraosseous implants or osteosynthesis elements. As well as indicating the benefits of FEA in mechanical parameter analysis, we also point out the assumptions and simplifications that are commonly used. The understanding of FEA’s opportunities and advantages as well as its limitations and main flaws is crucial to fully exploit its potential.

14 August 2021 in Materials
Verified
Journal Article
Open access
PDF file
MTMonika Teślak
Monika Teślak
AZAdam Ziemlewski
Adam Ziemlewski
IFIgor Foltyn
Igor Foltyn
IOIwona Ordyniec-Kwaśnica
Iwona Ordyniec-Kwaśnica
BDBarbara Drogoszewska
Barbara Drogoszewska
Introduction: Nowadays, the final success of implantation is not only based on obtaining osseointegration of the implant but is also determined by achieving a satisfactory aesthetic effect of the soft tissues surrounding the implant, which can be defined as an aesthetic integration. The process of obtaining this aesthetic integration already begins at the stage of placing the healing abutment, which allows us to obtain the emergence profile necessary for our prosthetic reconstruction. Materials and Methods: The study used cone-beam computer tomography (CBCT) scans of 51 patients. The measurements of the maxillary teeth (central incisor, lateral incisor, canine, first premolar, and first molar) were performed from cross-sections of the individual teeth at the transition zone to design a custom anatomic healing abutment milled from zirconium and luted to the non-index Ti-base. Results: The obtained results allowed to design and create the shape of the anatomic healing abutment. Conclusions: The use of laboratory-produced anatomical healing abutments is possible and may allow to obtain the desired and planned emergence profiles of prosthetic restorations. In addition, it might be a method of reducing work time at the dental chair but further clinical trials are necessary.

24 May 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MTMonika Teślak
Monika Teślak
HSHanna Sobczak-Jaskow
Hanna Sobczak-Jaskow
IOIwona Ordyniec-Kwaśnica
Iwona Ordyniec-Kwaśnica
BKBarbara Kochańska
Barbara Kochańska
BDBarbara Drogoszewska
Barbara Drogoszewska
Background: Medication-Related Osteonecrosis of the Jaws (MRONJ) is a serious complication of antiresorptive therapy. The aim of the study was to assess the level of knowledge and awareness regarding MRONJ among Polish dentists and students of dentistry. Methods: The online self-administered questionnaire was sent out electronically among dentists in Poland and dentistry students of the Medical University of Gdansk. The results obtained were statistically analyzed. The results were considered statistically significant if the condition p ≤ 0.05 was met. Results: A total of 203 respondents participated in this survey. A total of 94.6% of them declared knowledge of the term MRONJ. However, the length of bisphosphonates persistence in the body was known to 51.5% of participants, while the knowledge of oral and maxillofacial surgeons concerning this topic was significantly higher (87.0%). Conclusion: Dental and maxillofacial surgeons presented the highest level of knowledge about MRONJ. The remaining groups did not differ in their knowledge. It must be noted that the knowledge of the students was similar to that of dentists. A better level of knowledge by dentists could contribute to a decline of the occurrence of the disease in future. Theoretical and practical initiatives should be promoted to improve the knowledge about MRONJ.

2 June 2023 in Medicina
Verified
Journal Article
Open access
PDF file
HSHanna Sobczak-Jaskow
Hanna Sobczak-Jaskow
BKBarbara Kochańska
Barbara Kochańska
BDBarbara Drogoszewska
Barbara Drogoszewska
Background and Objectives: The aim of this study was to examine how the status of the oral cavity, composition and properties of saliva change in oncological patients with and without Medication-Related Osteonecrosis of the Jaw (MRONJ) undergoing bisphosphonate therapy. Materials and Methods: A retrospective case–control study of 49 oncological patients using bisphosphonates (BPs) was conducted. The study population was divided into two groups—Group I consisted of 29 patients with MRONJ and Group II of 20 patients without MRONJ. The control group consisted of 32 persons without oncological history and without antiresorptive therapy. Standard dental examination included the assessment of the number of teeth remaining, teeth with caries and fillings, Approximal Plaque Index (API) and Bleeding on Probing (BOP). In terms of MRONJ, localization and stage were assessed. Laboratory tests of saliva included determination of pH and concentrations of Ca and PO4 ions, total protein, lactoferrin, lysozyme, sIgA, IgA, cortisol, neopterin, activity of amylase at rest, and stimulated saliva. The buffering capacity and microbiological tests (Streptococcus mutans, Lactobacillus spp. load) of stimulated saliva were also determined. Results: There were no statistically significant differences between the selected oral parameters and saliva of Group I and Group II. Significant differences were found between Group I and the control group. BOP, lysozyme and cortisol concentration were higher, while the number of teeth with fillings, Ca and neopterin concentrations were lower in comparison to the control group. In Group I, a significantly higher percentage of patients with a high colony count (>105) of Streptococcus mutans and Lactobacillus spp. was also found. The significant differences between Group II and the control group concerned the concentrations of lysozyme, Ca ions, sIgA, neopterin and the colony count of Lactobacillus spp. In the Group I patients who received a significantly higher cumulative dose of BP compared to the Group II, a significant positive correlation was found between the received BP dose and the BOP. Most MRONJ foci were stage 2 and were mainly located in the mandible. Conclusions: Among oncological patients with and without MRONJ undergoing BP therapy compared to the control group, there are statistically significant differences in the dental, periodontal and microbiological status and in the composition of the saliva. Particularly noteworthy are the statistically significant differences in the decreased level of Ca ions, the increased level of cortisol and the elements of saliva related to the immune response (lysozyme, sIgA, neopterin). Additionally, a higher cumulative dose of BPs may affect the susceptibility to the development of osteonecrosis of the jaws. Patients undergoing antiresorptive therapy should receive multidisciplinary medical care, including dental care.

HSHanna Sobczak-Jaskow
Hanna Sobczak-Jaskow
BKBarbara Kochańska
Barbara Kochańska
BDBarbara Drogoszewska
Barbara Drogoszewska
The aim of this study was to examine how the composition and properties of saliva change in people with osteoporosis who have received antiresorptive (AR) treatment, compared to patients with osteoporosis who have not yet received this treatment. Methods: The study population consisted of 38 patients with osteoporosis using AR drugs (Group I) and 16 patients with osteoporosis who had never used AR drugs (Group II). The control group consisted of 32 people without osteoporosis. Laboratory tests included determination of pH and concentrations of Ca, PO4, total protein, lactoferrin, lysozyme, sIgA, IgA, cortisol, neopterin, activity of amylase at rest, and stimulated saliva. The buffering capacity of stimulated saliva was also determined. Results: There were no statistically significant differences between the saliva of Group I and Group II. No statistically significant correlation was found between the amount of time using AR therapy (Group I) and the tested parameters of the saliva. Significant differences were found between Group I and the control group. The concentrations of PO4, lysozyme, and cortisol were higher, while concentrations of Ca ions, sIgA, and neopterin were lower, in comparison to the control group. The significant differences between Group II and the control group were smaller, and they concerned only the concentrations of lysozyme, cortisol, and neopterin. Conclusions: The saliva of people with osteoporosis subjected to AR therapy and those not subjected to AR therapy did not show statistically significant differences in terms of the examined parameters of the saliva. However, the saliva of patients with osteoporosis taking and not taking AR drugs was significantly different compared to the saliva of the control group.

28 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JTJakub Tarnawski
Jakub Tarnawski
BWBarbara Wojciechowska
Barbara Wojciechowska
APAdam Polcyn
Adam Polcyn
ŁGŁukasz Garbacewicz
Łukasz Garbacewicz
BDBarbara Drogoszewska
Barbara Drogoszewska
Adam MichcikAdam Michcik
Adam Michcik
Background/Objectives: Oral mucosal melanoma is rare and associated with poor prognosis. This study aims to identify clinical and molecular factors influencing survival by synthesizing published cases together with one original case. Methods: A systematic review was conducted. Relevant clinical, histopathological, and follow-up parameters were compared across studies. Results: A total of 21 publications describing 42 patients were reviewed, and the data were aggregated with our patient, yielding 43 patients in total. Our case describing a 66-year-old male with 14 years of disease-free survival despite multiple excisions illustrated the potential for long-term survival despite poor prognosis. Favorable prognostic indicators listed in the literature included preserved expression of BAP1, p53, BCL2, and p16, the presence of tumor-infiltrating lymphocytes, smaller tumor size and thickness, and the absence of vascular invasion. Longer follow-up periods were most often observed in younger patients without lymphadenopathy, distant metastasis, or local recurrence. Conclusions: This review highlights prognostic features in oral mucosal melanoma but also underscores exceptions, demonstrating that survival cannot be fully explained by current clinical and molecular criteria.